These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19147530)

  • 21. Epigenome-metabolome-microbiome axis in health and IBD.
    Amatullah H; Jeffrey KL
    Curr Opin Microbiol; 2020 Aug; 56():97-108. PubMed ID: 32920333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health.
    Mai V; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):81-5. PubMed ID: 19115471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships.
    Plichta DR; Graham DB; Subramanian S; Xavier RJ
    Cell; 2019 Aug; 178(5):1041-1056. PubMed ID: 31442399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
    Bruner SD; Jobin C
    Clin Pharmacol Ther; 2016 Jun; 99(6):585-7. PubMed ID: 26850686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akkermansia muciniphila and its role in regulating host functions.
    Derrien M; Belzer C; de Vos WM
    Microb Pathog; 2017 May; 106():171-181. PubMed ID: 26875998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human gut microbiome: implications for future health care.
    Kinross JM; von Roon AC; Holmes E; Darzi A; Nicholson JK
    Curr Gastroenterol Rep; 2008 Aug; 10(4):396-403. PubMed ID: 18627653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiota regulation of inflammatory bowel disease and colorectal cancer.
    Liu Z; Cao AT; Cong Y
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):543-52. PubMed ID: 24071482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Food and the gut microbiota in inflammatory bowel diseases: a critical connection.
    Albenberg LG; Lewis JD; Wu GD
    Curr Opin Gastroenterol; 2012 Jul; 28(4):314-20. PubMed ID: 22573192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microbes of the intestine: an introduction to their metabolic and signaling capabilities.
    Hsiao WW; Metz C; Singh DP; Roth J
    Endocrinol Metab Clin North Am; 2008 Dec; 37(4):857-71. PubMed ID: 19026936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota and related diseases: clinical features.
    Stanghellini V; Barbara G; Cremon C; Cogliandro R; Antonucci A; Gabusi V; Frisoni C; De Giorgio R; Grasso V; Serra M; Corinaldesi R
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S57-63. PubMed ID: 20865476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease.
    Deuring JJ; de Haar C; Kuipers EJ; Peppelenbosch MP; van der Woude CJ
    Int J Biochem Cell Biol; 2013 Apr; 45(4):798-806. PubMed ID: 23291352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irritable bowel syndrome, inflammatory bowel disease and the microbiome.
    Major G; Spiller R
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):15-21. PubMed ID: 24296462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease.
    Greenblum S; Turnbaugh PJ; Borenstein E
    Proc Natl Acad Sci U S A; 2012 Jan; 109(2):594-9. PubMed ID: 22184244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta'omic analytic techniques for studying the intestinal microbiome.
    Morgan XC; Huttenhower C
    Gastroenterology; 2014 May; 146(6):1437-1448.e1. PubMed ID: 24486053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.
    Hoffmann TW; Pham HP; Bridonneau C; Aubry C; Lamas B; Martin-Gallausiaux C; Moroldo M; Rainteau D; Lapaque N; Six A; Richard ML; Fargier E; Le Guern ME; Langella P; Sokol H
    ISME J; 2016 Feb; 10(2):460-77. PubMed ID: 26218241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative interactions with the microbiota: IBD.
    Salzman NH; Bevins CL
    Adv Exp Med Biol; 2008; 635():67-78. PubMed ID: 18841704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome.
    Knights D; Lassen KG; Xavier RJ
    Gut; 2013 Oct; 62(10):1505-10. PubMed ID: 24037875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal control of the intestinal microbial community.
    Brugman S; Nieuwenhuis EE
    J Mol Med (Berl); 2010 Sep; 88(9):881-8. PubMed ID: 20523962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiota and the role of probiotics in therapy.
    Quigley EM
    Curr Opin Pharmacol; 2011 Dec; 11(6):593-603. PubMed ID: 21996283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.